Impact and Diagnosis of Antiplatelet Therapy Resistance in Patients Undergoing Cardiac Surgery. Issue 7 (21st October 2013)
- Record Type:
- Journal Article
- Title:
- Impact and Diagnosis of Antiplatelet Therapy Resistance in Patients Undergoing Cardiac Surgery. Issue 7 (21st October 2013)
- Main Title:
- Impact and Diagnosis of Antiplatelet Therapy Resistance in Patients Undergoing Cardiac Surgery
- Authors:
- Gasparovic, Hrvoje
Petricevic, Mate
Biocina, Bojan
Gurwitz, David - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <p> <table-wrap position="anchor" orientation="portrait"> <label> <x xml:space="preserve">Table </x> </label> <table border="1"> <colgroup span="1"> <col align="left" span="1" /> </colgroup> <tbody> <tr> <td align="left" rowspan="1" colspan="1">Clinical Development Phases I‐III Regulatory, Quality, Manufacturing</td> </tr> </tbody> </table> </table-wrap> </p> <p>Coronary artery bypass grafting (CABG) is highly effective in the treatment of severe coronary artery disease. Antiplatelet therapy is a critical component of the medical management of patients following CABG. Patient idiosyncrasies in responsiveness to antiplatelet agents, however, lead to variable suppression of platelet aggregation. This problem is underscored by inconsistent findings from the different laboratory instruments used to document antiplatelet drug responsiveness and its uncertain clinical impact. The laboratory results reveal a spectrum of platelet inhibition effects. The cutoff values discriminating between "resistance" and "response" to antiplatelet therapy often rely solely on definition. It is therefore not surprising that regular testing for antiplatelet therapy response has neither been routinely instituted in a wider clinical arena nor is there unequivocal evidence to support it. The purpose of this review is to offer insight into the incidence and clinical impact of antiplatelet therapy resistance in patients undergoing surgical<abstract abstract-type="main"> <title>Abstract</title> <p> <table-wrap position="anchor" orientation="portrait"> <label> <x xml:space="preserve">Table </x> </label> <table border="1"> <colgroup span="1"> <col align="left" span="1" /> </colgroup> <tbody> <tr> <td align="left" rowspan="1" colspan="1">Clinical Development Phases I‐III Regulatory, Quality, Manufacturing</td> </tr> </tbody> </table> </table-wrap> </p> <p>Coronary artery bypass grafting (CABG) is highly effective in the treatment of severe coronary artery disease. Antiplatelet therapy is a critical component of the medical management of patients following CABG. Patient idiosyncrasies in responsiveness to antiplatelet agents, however, lead to variable suppression of platelet aggregation. This problem is underscored by inconsistent findings from the different laboratory instruments used to document antiplatelet drug responsiveness and its uncertain clinical impact. The laboratory results reveal a spectrum of platelet inhibition effects. The cutoff values discriminating between "resistance" and "response" to antiplatelet therapy often rely solely on definition. It is therefore not surprising that regular testing for antiplatelet therapy response has neither been routinely instituted in a wider clinical arena nor is there unequivocal evidence to support it. The purpose of this review is to offer insight into the incidence and clinical impact of antiplatelet therapy resistance in patients undergoing surgical myocardial revascularization.</p> </abstract> … (more)
- Is Part Of:
- Drug development research. Volume 74:Issue 7(2013)
- Journal:
- Drug development research
- Issue:
- Volume 74:Issue 7(2013)
- Issue Display:
- Volume 74, Issue 7 (2013)
- Year:
- 2013
- Volume:
- 74
- Issue:
- 7
- Issue Sort Value:
- 2013-0074-0007-0000
- Page Start:
- 492
- Page End:
- 504
- Publication Date:
- 2013-10-21
- Subjects:
- Drug development -- Periodicals
Drugs -- Research -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2299 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ddr.21107 ↗
- Languages:
- English
- ISSNs:
- 0272-4391
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.119000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3045.xml